DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Llaneras J, Barciela MR, Lens S. , et al.
Real-life effectiveness and safety of velpatasvir/sofosbuvir/voxilaprevir for previously DAA-treated patients with chronic hepatitis C.
Hepatology 2018;
68 (Suppl.): 405A
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.